Literature DB >> 19152335

Altered BAFF-receptor signaling and additional modifier loci contribute to systemic autoimmunity in A/WySnJ mice.

Christopher G Mayne1, Faye E Nashold, Yoshiteru Sasaki, Colleen E Hayes.   

Abstract

Systemic lupus erythematosus pathology reflects autoantibody-mediated damage due to a failure of B-lymphocyte tolerance. We previously reported that B-lymphopenic A/WySnJ mice develop a lupus-like syndrome and linked this syndrome to the B-cell maturation defect-1 (Bcmd-1) mutant allele of the B-cell-activating factor belonging to the TNF family-receptor (Baffr) gene. Here, we further evaluate the genetic basis for autoimmunity in A/WySnJ mice. We produced B6.Bcmd-1 and AW.Baffr(-/-) congenic mice (N5), and compared them with B6.Baffr(-/-) and A/WySnJ mice with respect to B-lymphocyte development. Bcmd-1-expressing mice had more B cells with greater maturity than Baffr(-/-) mice regardless of genetic background, indicating that Bcmd-1 encodes a partially functional BAFF-R. We also compared these mice for lupus phenotypes to determine whether Bcmd-1 is necessary and sufficient for disease, or whether the Baffr(-/-) (-) allele can also cause autoimmunity. The Baffr(-/-) allele did not lead to autoimmunity on either genetic background. In contrast, the Bcmd-1 allele was necessary and sufficient for development of low levels of IgM autoantibodies in B6.Bcmd-1 mice. However, Bcmd-1 plus unidentified A/WySnJ modifier genes were necessary for development of IgG autoantibodies and renal pathology. We propose that in A/WySnJ mice an excess of BAFF per B cell rescues self-reactive B cells through a partially functional BAFF-R in a B-lymphopenic environment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19152335      PMCID: PMC2747311          DOI: 10.1002/eji.200838569

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  41 in total

1.  BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.

Authors:  J S Thompson; S A Bixler; F Qian; K Vora; M L Scott; T G Cachero; C Hession; P Schneider; I D Sizing; C Mullen; K Strauch; M Zafari; C D Benjamin; J Tschopp; J L Browning; C Ambrose
Journal:  Science       Date:  2001-08-16       Impact factor: 47.728

2.  The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21.

Authors:  A Cariappa; M Tang; C Parng; E Nebelitskiy; M Carroll; K Georgopoulos; S Pillai
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

3.  Regulation of the T-independent humoral response by TACI.

Authors:  G U von Bülow; J M van Deursen; R J Bram
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

4.  Cutting edge: A/WySnJ transitional B cells overexpress the chromosome 15 proapoptotic Blk gene and succumb to premature apoptosis.

Authors:  I J Amanna; K Clise-Dwyer; F E Nashold; K A Hoag; C E Hayes
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

5.  Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency.

Authors:  M Yan; J R Brady; B Chan; W P Lee; B Hsu; S Harless; M Cancro; I S Grewal; V M Dixit
Journal:  Curr Biol       Date:  2001-10-02       Impact factor: 10.834

Review 6.  Delineating the genetic basis of systemic lupus erythematosus.

Authors:  E K Wakeland; K Liu; R R Graham; T W Behrens
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

7.  An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.

Authors:  B Schiemann; J L Gommerman; K Vora; T G Cachero; S Shulga-Morskaya; M Dobles; E Frew; M L Scott
Journal:  Science       Date:  2001-08-16       Impact factor: 47.728

8.  A quantitative-trait locus controlling peripheral B-cell deficiency maps to mouse Chromosome 15.

Authors:  K A Hoag; K Clise-Dwyer; Y H Lim; F E Nashold; J Gestwicki; M P Cancro; C E Hayes
Journal:  Immunogenetics       Date:  2000-09       Impact factor: 2.846

9.  Systemic autoimmunity in BAFF-R-mutant A/WySnJ strain mice.

Authors:  Christopher G Mayne; Ian J Amanna; Faye E Nashold; Colleen E Hayes
Journal:  Eur J Immunol       Date:  2008-02       Impact factor: 5.532

10.  Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.

Authors:  F Mackay; S A Woodcock; P Lawton; C Ambrose; M Baetscher; P Schneider; J Tschopp; J L Browning
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

View more
  4 in total

1.  Murine BAFF-receptor residues 168-175 are essential for optimal CD21/35 expression but dispensable for B cell survival.

Authors:  Christopher G Mayne; Ian J Amanna; Colleen E Hayes
Journal:  Mol Immunol       Date:  2009-10-07       Impact factor: 4.407

2.  A Complex Relationship between TRAF3 and Non-Canonical NF-κB2 Activation in B Lymphocytes.

Authors:  Wai W Lin; Joanne M Hildebrand; Gail A Bishop
Journal:  Front Immunol       Date:  2013-12-20       Impact factor: 7.561

Review 3.  Non-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple Junctures.

Authors:  Sandra Gardam; Robert Brink
Journal:  Front Immunol       Date:  2014-01-06       Impact factor: 7.561

4.  MRL Strains Have a BAFFR Mutation without Functional Consequence.

Authors:  Windy R Allman; Lunhua Liu; Adam S Coleman; Mustafa Akkoyunlu
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.